$AQST
Aquestive Therapeutics Inc
PRICE
$0.86 โฒ2.381%
Last Close
VOLUME
151,401
DAY RANGE
0.8201 - 0.86
52 WEEK
0.618 - 2.81
Key Metrics
Market Cap
45.49 M
Beta
1.34
Avg. Volume
319.40 K
Shares Outstanding
54.16 M
Yield
0%
Public Float
0
Next Earnings Date
2023-05-02
Next Dividend Date
Company Information
Aquestive Therapeutics is a pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients. The Company has commercialized one internally-developed proprietary product to date, Sympazan, has a commercial proprietary product pipeline focused on the treatment of diseases of the central nervous system, or CNS, and other unmet needs, and is developing orally administered complex molecules to provide alternatives to invasively administered standard of care therapies. The Company also collaborates with other pharmaceutical companies to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilmยฎ, and has proven capabilities for drug development and commercialization.
Website: aquestive.com
HQ: ,
Related News